Study: PEATY
24/09/2024

Patients' experiences of abemaciclib plus endocrine therapy (ET) in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (EBC): a preliminary qualitative interview study

Study: IMPACTOR
24/09/2024

Early supportive interventions needed to reduce treatment burden of abemaciclib + endocrine therapy in metastatic breast cancer

Study: TRUSTING Workshops 2022-23 Evaluation
30/06/2024

Roll out and influence of an educational program Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING)

Study: IMPARTER 4
30/05/2024

IMproving PAtient UndeRstanding of GEP TEst Results (IMPARTER4)

Study: TRUSTING Workshops 2022-23 Evaluation
22/01/2024

Roll out and influence on practice of the Talking about Risk, Uncertainties of Testing in Genetics (TRUSTING) educational programme

Study: PRRS - Patient Roles and Responsibilities Scale
22/01/2024

The Patient Roles and Responsibilities Scale (PRRS): a psychometrically robust and useful tool to measure what matters most to patients

Study: LORIS
22/01/2024

The challenges of recruiting women with low-risk ductal carcinoma in situ to a randomised controlled trial: the LORIS study experience

Study: IMPARTER 4
19/01/2024

IMPARTER:4 IMproving PAtient undeRstanding of Gene Expression Profiling Test Results: Phase 4

Study: LIMBER
19/01/2024

Exploring the support needs of women LIvingwith Metastatic Breast cancER: a qualitative analysis of the LIMBER survey

Study: LIMBER 2 - They just don't know what to say or do
09/11/2023

Development of an information film for friends & family of patients with MBC "They just don't know what to say or do"

Study: DIAMOND Phase 1-4
06/12/2022

'Gastrostomy Tube: Is it for Me?' Development and pilot testing of a web-based patient decision aid for people with motor neurone disease considering a gastrostomy tube (DiAMoND Study)

Study: DIAMOND Phase 1-4
28/11/2022

Development and pilot testing of a web-based decision aid for people with motor neurone disease considering a gastrostomy tube (DiAMoND Study)

Study: IMPARTER Phase 1
07/12/2021

An intervention to help improve understanding of gene expression profiling tests in breast cancer: Which is best, an information film or leaflet?

Study: PRAGMATIC
11/11/2021

Patients' experiences of a suppoRtedself-manAGeMentpAThwayIn breast Cancer (PRAGMATIC): 3 month Quality of Life Results

Study: PRAGMATIC
11/11/2021

Patients' experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC)

Study: REFLECTIONS
11/11/2021

Oncologists and patients believe more training is needed in telehealth and carers and nurses need inclusion

Study: Nepal womens cancer scoping review (IRP)
01/11/2021

A scoping review to determine levels of knowledge, attitudes and screening practices towards breast and cervical cancer among women in Nepal

Study: Transgender project (IRP)
01/11/2021

A scoping review of cancer screening in the transgender population: uptake, barriers and healthcare professional knowledge

Study: TRUSTING Workshops 2020-21 Evaluation
01/04/2021

TRUSTING: The development of a communication program for healthcare professionals talking about risk and uncertainty of testing in genetics

Study: PRAGMATIC
27/02/2020

Patients' experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC)

Study: PROACT
27/02/2020

Identifying trigger items from the Patient Roles and Responsibilities Scale

Study: Q-ABC
01/02/2020

Quality of Life After Bladder Cancer

Study: Related
01/02/2020

Measuring diarrhoea in a cancer setting: the importance of patient-reported tools

Study: TARGET Workshops - Talking About Risk in the context of Genomic Tests (TARGET)
19/12/2019

Results from a novel education program to help nurses when discussing the Onoctype DX Breast Recurrence Score test with their patients

Study: POSNOC
06/10/2019

Measuring patient reported outcomes in the POSNOC trial: Strategies employed to promote high quality data return

Study: TARGET Workshops - Talking About Risk in the context of Genomic Tests (TARGET)
11/04/2019

Talking About Risk in the Context of GEnomicTests (TARGET) Evaluation of an educational programme

Study: AVALPROFS
04/11/2018

Hoping against hope: Are patients' expectations and understanding about therapeutic aims of novel drugs similar to their oncologists?

Study: Extreqol
19/10/2018

Patients' and partners' views of treatment and care provided for metastatic castrate resistant prostate cancer (mCRPC) in the UK

Study: PEPSIN
01/03/2018

PEPSIN Psychobiological Effects of Personalised Supportive INterventions: a feasibility study

Study: LORIS
05/12/2017

Interviews with women contemplating LORIS trial entry: 2 year feasibility study

Study: PROACT
01/11/2017

Evaluation of Construct and Structural Validity in the Patient Roles and Responsibilities Scale

Study: ENDOPREDICT
08/09/2017

Enhanced decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing

Study: CU FITTER
22/06/2017

How to keep active with cancer? Cancer survivors' experiences of a tailored exercise programme CUFITTERTM: results of an explorative survey

Study: Extreqol
16/06/2017

Survey Results on Managing Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Study: PulMiCC
01/05/2017

Patients' views on the PulMiCC trial information: Results from a survey

Study: CU FITTER
16/03/2017

Exercise levels and experiences of those attending CUFITTER a tailored exercise programme for people incancer recovery

Study: PROACT
01/03/2017

Patient Reported Outcomes in cancer, impact of Age and Carer role demands associated with Treatment (PROACT): The 'lucky' construct

Study: AVALPROFS
27/01/2017

Assessing the VALue to patients of PROgression Free Survival (AVALPROFS) Quality of Life Results

Study: PROACT
01/01/2017

Evaluation and validation of the proact measures for cancer patients and informal caregivers

Study: PrefHer
01/10/2016

Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study

Study: PROACT
01/10/2016

Patient Reported Outcomes in Cancer, Impact of Age and Carer Role Demands Associated with Treatment (PROACT): Phase 1 Development of Scale Items

Study: bWell Videos
09/03/2016

bWell: a mobile application for self-management of arm and shoulder exercises after breast cancer treatment

Study: PROACT
27/09/2015

Uncertainty about the future for patients with advanced cancer and their informal caregivers: A qualitative view

Study: PROACT
27/09/2015

Measuring the impact of extended cancer survival on broader aspects of life and well being: The PROACT study

Study: EXPECT
25/09/2015

Gaps and inconsistencies: Information for men with metastatic castrate resistant prostate cancer (mCRPC)

Study: PROACT
02/09/2015

Patient reported outcome measures for cancer caregivers: A systematic review

Study: Chemotherapy and Cognition
18/03/2015

Feasibility study to examine underlying mechanisms for "chemo-cog"

Study: AVALPROFS
01/01/2014

Assessing the VALue of PROgression Free Survival (AVALPROFS)

Study: PrefHer
01/09/2013

Reasons for patients' preferences for subcutaneous or intravenous trastuzumab in the PrefHer study

Study: PrefHer
01/03/2013

PATIENT PREFERENCE FOR SUBCUTANEOUS VERSUS INTRAVENOUS ADJUVANT TRASTUZUMAB: RESULTS OF THE PREFHER STUDY

Study: Teams Talking Trials
01/01/2010

Communication skills training for breast cancer teams talking about trials

Study: ALMANAC
03/12/2004

Impact of sentinel node biopsy on quality of life in the ALMANAC trial.

Study: Communicating about RCTs films
21/05/2004

Efficacy of an Intervention to Improve Communication About Randomised Clinical Trials (RCTs) in Cancer